Syneron Medical Ltd (ELOS) Posts Q3 EPS of $0.03, Sales Top Expectations
Syneron Medical Ltd (NASDAQ: ELOS) reported Q3 EPS of $0.03, which may not compare to the analyst estimate of ($0.11). Revenue for the quarter came in at $57 million versus the consensus estimate of $50.66 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PTC (PTC) Tops Q1 EPS by 1c; Updates FY15 Outlook
- Silicom Ltd (SILC) Tops Q3 EPS by 22c
- TCF Financial Corp. (TCB) Posts Q4 EPS of $0.12
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!